Celgene (CELG)

104.99 +0.29 (0.28%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (10/25/19 *Est.)
- M&A (9/30/19 *Est)

Latest Headlines

Bristol-Myers Squibb Company Announces Extension of the Expiration Date for Exchange Offers for Celgene Corporation Notes October 18, 2019 6:59 AM - BizWire Celgene and the Multiple Sclerosis Association of America Take the MS MindShift Initiative and “Brain Bulb” Hot Air Balloon to the Sky at Owl-O-Ween Festival to Educate on Multiple Sclerosis and B October 16, 2019 6:00 AM - BizWire Bernstein Reinstates Celgene (CELG) at Market Perform October 14, 2019 7:00 AM - StreetInsider State Street Global Advisors Announces Impact of Receiving Payment October 9, 2019 6:38 PM - BizWire Bristol-Myers Squibb Company Announces Extension of the Expiration Date for Exchange Offers for Celgene Corporation Notes October 8, 2019 6:59 AM - BizWire  Bristol-Myers Squibb Company Announces Extension of the Expiration Date for Exchange Offers for Celgene Corporation Notes September 23, 2019 6:59 AM - BizWire Celgene Corporation Names Second Round of Celgene Cancer Care Links™ Program Grant Recipients September 20, 2019 7:30 AM - BizWire Form 4 CELGENE CORP /DE/ For: Sep 18 Filed by: Curran Terrie September 19, 2019 4:05 PM - SEC Filing Celgene (CELG) Phase 3 QUAZAR AML-001 Study of CC-486 as Maintenance Therapy in Patients With Newly Diagnosed AML Met Primary and Key Secondary Endpoints September 12, 2019 4:30 PM - StreetInsider Celgene Announces Phase 3 QUAZAR® AML-001 Study of CC-486 as Maintenance Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia Met Primary and Key Secondary Endpoints September 12, 2019 4:30 PM - BizWire Data from Ozanimod Clinical Development Program in Relapsing Forms of Multiple Sclerosis to Be Presented at the 35th Congress of the European Committee for Treatment and Research in Multiple Sclerosis September 9, 2019 7:30 AM - BizWire Amgen (AMGN) PT Raised to $218 at Piper Jaffray August 26, 2019 12:30 PM - StreetInsider Pre-Open Movers 08/26: (FBIO) (MDCO) (PBI) Higher (ALXN) (CREE) (AMGN) Lower (more...) August 26, 2019 9:28 AM - StreetInsider Surprise... Amgen (AMGN) Didn't Buy Alexion Pharma (ALXN) August 26, 2019 9:15 AM - StreetInsider Wall Street bounces as trade temperature cools August 26, 2019 8:00 AM - StreetInsider Form 8-K CELGENE CORP /DE/ For: Aug 25 August 26, 2019 7:31 AM - SEC Filing Bristol-Myers Squibb (BMY) Gains 5% on Celgene's Deal to Sell Otezla to Amgen August 26, 2019 6:50 AM - StreetInsider Amgen (AMGN) to Acquire Otezla from Celgene (CELG) for $13.4B August 26, 2019 6:32 AM - StreetInsider Amgen To Acquire Otezla® For $13.4 Billion In Cash, Or Approximately $11.2 Billion Net Of Anticipated Future Cash Tax Benefits August 26, 2019 6:30 AM - PR NewsWire Bristol-Myers Squibb Announces Agreement Between Celgene and Amgen to Divest OTEZLA® for $13.4 Billion August 26, 2019 6:30 AM - BizWire Mizuho Securities Downgrades Celgene (CELG) to Neutral August 19, 2019 7:03 AM - StreetInsider Celgene (CELG) Announces U.S. FDA Approval of INREBIC as Treatment for Myelofibrosis August 16, 2019 10:31 AM - StreetInsider U.S. FDA Approves INREBIC® (Fedratinib) as First New Treatment in Nearly a Decade for Patients With Myelofibrosis August 16, 2019 10:30 AM - BizWire Paulson's 13F Shows New Stakes in Sotheby's (BID), Lyft (LYFT), Increase in Allergan (AGN), Sprint (S) (more...) August 14, 2019 5:10 PM - StreetInsider Baupost's 13F Shows New Stake in XPO Logistics (XPO), Increase in Bristol-Myers Squibb (BMY), CBS (CBS), Liquidated Celgene (CELG) (More...) August 13, 2019 5:28 PM - StreetInsider Third Point's 13F Shows New Stakes in Centene (CNC), GTT Communications (GTT), Tradeweb (TW), Increased Stake in Boston Scientific (BSX) (More...) August 13, 2019 6:30 AM - StreetInsider Form 4 CELGENE CORP /DE/ For: Aug 01 Filed by: Elkins David V August 5, 2019 4:00 PM - SEC Filing Form 10-Q CELGENE CORP /DE/ For: Jun 30 July 30, 2019 4:12 PM - SEC Filing Celgene (CELG) PT Lowered to $96 at RBC Capital July 30, 2019 3:57 PM - StreetInsider Form 8-K CELGENE CORP /DE/ For: Jul 30 July 30, 2019 7:43 AM - SEC Filing Celgene (CELG) Tops Q2 EPS by 23c, Raises Gudiance July 30, 2019 7:35 AM - StreetInsider Celgene Reports Second Quarter 2019 Operating and Financial Results July 30, 2019 7:30 AM - BizWire Bristol-Myers Squibb (BMY) Announces European Commission Approval of Pending Acquisition of Celgene (CELG) July 29, 2019 10:10 AM - StreetInsider Bristol-Myers Squibb Announces European Commission Approval of Pending Acquisition of Celgene July 29, 2019 10:10 AM - BizWire Pfizer to spinoff, merge off-patent drugs unit with Mylan July 29, 2019 7:01 AM - StreetInsider Hach Rose Schirripa & Cheverie LLP Announces $55 Million Settlement in Antitrust Class Action Against Celgene July 26, 2019 1:25 PM - StreetInsider Eliquis, Orencia sales propel Bristol-Myers to strong second quarter July 25, 2019 10:35 AM - StreetInsider Full Article List